Rhode Island Senate Bill S2561

Rhode Island 2026 Regular Session

• Introduced: 2/13/26
• Refer: 2/13/26

Caption

Limits prior authorization requirements for rehabilitative and habilitative services. Also prohibits prior authorization for the first twelve (12) visits of a new episode of care and for ninety (90) days following a chronic pain diagnosis.

Impact

The introduction of S2561 is expected to significantly change the landscape for patients seeking rehabilitation and pain management services. By reducing the administrative burden related to prior authorizations, the bill empowers patients and providers, facilitating quicker access to necessary treatments. This move may particularly benefit those with chronic pain conditions, who often face barriers in obtaining timely and effective nonpharmacologic management options. The requirement for insurance plans to respond to prior authorization requests within twenty-four hours and the automatic approval criteria for delays are also notable improvements aimed at enhancing patient care.

Summary

Senate Bill S2561, introduced in 2026, aims to amend the regulation of health insurance plans by limiting prior authorization requirements for rehabilitative and habilitative services. The bill stipulates that an individual or group health insurance plan cannot require prior authorization for the first twelve visits of a new episode of care, which is defined as treatment for a new or recurring condition that has not been previously treated by the provider within the last ninety days. Additionally, the bill proposes that no prior authorization be needed for ninety days following the diagnosis of chronic pain.

Contention

Although S2561 is positioned as a means of improving access to rehabilitative services, it could encounter opposition from insurance companies concerned about the financial implications of mandating quicker approvals and limiting authorization for additional visits. Skeptics may argue that while the bill addresses urgent patient needs, it could lead to increased costs for insurers if not properly balanced with measures that ensure the medical necessity of extended therapy services. Furthermore, the delineation of what constitutes a 'new episode of care' may also spark debate, with potential concerns over abuse of this classification to sidestep necessary authorizations.